Assessing the cost-effectiveness of homeopathic medicines: Are the problems different from other health technologies?

Homeopathy

Volumn 89, Issue 1 SUPPL. 1, 2000, Pages

  Buxton, M ^a  

^a BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; DRUG INDUSTRY; EVIDENCE BASED MEDICINE; HOMEOPATHY; MEDICAL TECHNOLOGY; REVIEW;

COST-BENEFIT ANALYSIS; EVIDENCE-BASED MEDICINE; GREAT BRITAIN; HOMEOPATHY; HUMANS;

EID: 0033854201     PISSN: 14754916     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bhj.5800374     Document Type: Article

References (14)

1. Buxton MJ. Scarce resources and informed choices. In: Ashton D (ed.) Future Trends in Medicine (Congress and Symposium Series no 202. London: RSM, 1993.
2. New B, Le Grand J. Rationing in the NHS: Principles and Pragmatism. London: King's Fund, 1996.
3. Sackett DL, Rosenberg WM, Gray JAM, Haynes RB, Richardsom WS. Evidence based medicine: what it is and what it isn't. BMJ 1996; 312: 71-72.
4. Advisory Group on Health Technology Assessment. Assessing the Effects of Health Technologies: Principles, Practice, Proposals. London: Department of Health (Research and Development Division), 1992.
5. Chalmers I, Enkin M, Keirse MJ. Preparing and updating systematic reviews of randomised controlled trials of health care. Milbank Q 1993; 71(3): 411-437.
6. National Coordinating Centre for Health Technology Assessment. The Annual Report of the NHS Health Technolgy Assessment Programme 1998. London: Department of Health, 1998.
7. DiMasi JA, Hansen RW, Grabowski HG, Lasagna L. The cost of innovation in the pharmaceutical industry. J Health Econ 1991; 10: 107-142.
8. Horton R. Surgical research or comic opera: questions, but few answers. Lancet 1996; 347: 984-985.
9. NHS Executive Faster Access to Modern Treatment: How NICE Appraisal Will Work: A Discussion Paper. Leeds: Department of Health (Pharmaceutical and Prescribing Branch). Int J Technol Assess Health Care 1999; 15: 340-351.
10. Van Haselen R. Evidence influencing British Health Authorities' decisions in purchasing complementary medicine. J Am Med Assoc 1998; 280(18): 1564-1565.
11. Gold MR, Seigel JE, Russell LB, Weinstein MC. Cost-Effectiveness in Health and Medicine. New York. Oxford University Press, 1966, Chap 4.
12. Ryan M. Using Consumer Preferences in Health Care Decision Making: The Application of Conjoint Analysis. London: Office of Health Economics, 1996.
13. Bryan S, Buxton MJ, Sheldon R, Grant A. Magnetic resonance Imaging for the investigation of knee injuries: an investigation of preferences. Health Econ 1998; 7: 595-603.
14. Ratcliffe J , Buxton MJ. Patients' preferences regarding the process and outcomes of high technology medicine: an application of conjoint analysis to liver transplantation. Int J Technol Assess Health Care 1999; 15(2): 340-351